BeStock  

Avantor AVTR

US equityMarket cap rank #1410Medical Instruments & Supplies
$14.84 −$0.28 (-1.85%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.96 +0.81%
Open$15.11
Prev close$15.12
Day range$14.79 – $15.59
Volume12.26M
Market cap$10.06B
P/E (TTM)29.7
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.70B+4.6% YoY
Operating profit$139.50M+2.4% YoY
Net profit$203.40M+128.6% YoY
Diluted EPS$0.30+128.8% YoY
Free cash flow$156.20M-9.0% YoY
Operating cash flow$195.10M

Revenue, last 8 quarters

$1.7BDec '24$1.6BMar '25$1.7BJun '25$1.6BSep '25$1.7BDec '25$1.6BMar '26$1.7BJun '26$1.7BSep '26

Net profit, last 8 quarters

$500.4MDec '24$64.5MMar '25$64.7MJun '25$-711.8MSep '25$52.4MDec '25$43.3MMar '26$38.1MJun '26$203.4MSep '26

Diluted EPS by quarter

0.73Dec '240.09Mar '250.09Jun '25-1.04Sep '250.08Dec '250.06Mar '260.06Jun '260.30Sep '26

Free cash flow by quarter

$145.8MDec '24$81.3MMar '25$124.8MJun '25$171.7MSep '25$117.2MDec '25$25.2MMar '26$140.6MJun '26$156.2MSep '26

Annual revenue

$6.4BFY20$7.4BFY21$7.5BFY22$7.0BFY23$6.8BFY24$6.6BFY25

Profitability & balance sheet

Gross margin31.6%
Operating margin7.4%
Net margin5.1%
Return on equity5.9%
Return on assets2.9%
Return on invested capital4.6%
Current ratio1.89
Liabilities / assets49.8%
Cash & investments$464.30M
Total debt$3.68B
Net cash (debt)-$3.22B
Free cash flow / sales6.6%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • VWR Distribution & Services$1.23B 72.6%
  • Bioscience & Medtech Products$464.50M 27.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.70B $1.69B $1.58B $6.55B $1.66B
Total Operating Revenue $1.70B $1.69B $1.58B $6.55B $1.66B
Cost of Revenue $1.16B $1.16B $1.08B $4.41B $1.14B
Gross Profit $534.80M $537.00M $500.70M $2.14B $523.90M
Operating Expense $395.30M $415.20M $401.20M $1.60B $392.40M
Selling and Admin Expenses $395.30M $415.20M $401.20M $1.60B $392.40M
Operating Profit $139.50M $121.80M $99.50M $543.90M $131.50M
Net Non-Operating Interest Income (Expense) -$39.90M -$39.40M -$42.90M -$169.80M -$40.00M
Non-Operating Interest Expense $39.90M $39.40M $42.90M $169.80M $40.00M
Other Income (Expense) -$1.60M -$1.20M -$1.10M -$815.40M -$10.70M
Gain on Sale of Security -$300,000.00 -$100,000.00 – -$7.70M -$2.10M
Special Income (Charges) -$800,000.00 -$600,000.00 -$600,000.00 -$794.70M -$9.50M
-Less:Impairment of Capital Assets $0.00 – – $785.00M $0.00
-Less:Other Special Charges $800,000.00 $600,000.00 $600,000.00 $4.60M $4.40M
Other Non-Operating Income (Expenses) -$500,000.00 -$500,000.00 -$500,000.00 -$13.00M $900,000.00
Pretax Profit $98.00M $81.20M $55.50M -$441.30M $80.80M
Tax -$105.40M $43.10M $12.20M $88.90M $28.40M
Net Profit $203.40M $38.10M $43.30M -$530.20M $52.40M
Profit from Continuing Operations $203.40M $38.10M $43.30M -$530.20M $52.40M
Net Income to Parent Company $203.40M $38.10M $43.30M -$530.20M $52.40M
Net Income to Common Stockholders $203.40M $38.10M $43.30M -$530.20M $52.40M
Basic EPS $0.30 $0.06 $0.06 -$0.78 $0.08
Diluted EPS $0.30 $0.06 $0.06 -$0.78 $0.08
-Gain on Sale Of Business – – – -$5.10M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $11.63B $11.60B $11.66B $11.79B $11.79B
Total Current Assets $2.59B $2.46B $2.40B $2.45B $2.45B
Cash and Cash Equivalents & Short-Term Investments $464.30M $306.80M $279.30M $365.40M $365.40M
-Cash and Cash Equivalents $464.30M $306.80M $279.30M $365.40M $365.40M
Receivables $1.12B $1.14B $1.10B $1.07B $1.07B
-Accounts Receivable $1.12B $1.14B $1.10B $1.07B $1.07B
Inventory $854.80M $828.70M $810.30M $818.20M $818.20M
Other Current Assets $150.60M $187.80M $209.90M $193.00M $193.00M
Total Non-Current Assets $9.04B $9.13B $9.26B $9.34B $9.34B
Net PPE $778.90M $772.10M $766.20M $766.80M $766.80M
-Gross PPE $1.59B $1.56B $1.53B $1.51B $1.51B
-Accumulated Depreciation -$813.40M -$787.40M -$765.50M -$744.70M -$744.70M
Goodwill and Other Intangible Assets $7.86B $7.95B $8.05B $8.18B $8.18B
-Goodwill $4.93B $4.94B $4.95B $4.99B $4.99B
-Other Intangible Assets $2.93B $3.01B $3.10B $3.19B $3.19B
Other Non-Current Assets $400.30M $412.00M $441.70M $396.00M $396.00M
Total Liabilities $5.79B $5.97B $6.07B $6.23B $6.23B
Total Current Liabilities $1.37B $1.38B $1.37B $1.38B $1.38B
Payables $735.40M $743.20M $735.50M $741.70M $741.70M
-Accounts Payable $735.40M $743.20M $735.50M $741.70M $741.70M
Current Accrued Expenses $31.50M $46.20M $31.60M $47.30M $47.30M
Short-Term Debt and Capital Lease Obligation $35.00M $37.00M $37.00M $30.80M $30.80M
-Current Debt $35.00M $37.00M $37.00M $30.80M $30.80M
Other Current Liabilities $393.10M $398.40M $401.50M $396.40M $396.40M
Total Non-Current Liabilities $4.43B $4.58B $4.71B $4.85B $4.85B
Long Term Debt and Capital Lease Obligation $3.65B $3.66B $3.78B $3.92B $3.92B
-Long Term Debt $3.65B $3.66B $3.78B $3.92B $3.92B
Non-Current Deferred Liabilities $401.90M $539.90M $550.40M $557.10M $557.10M
Other Non-Current Liabilities $374.40M $383.00M $377.30M $378.20M $378.20M
Total Equity $5.84B $5.63B $5.59B $5.57B $5.57B
Stockholders' Equity $5.84B $5.63B $5.59B $5.57B $5.57B
Capital Stock $4.03B $4.01B $3.99B $3.98B $3.98B
-Common Stock $4.03B $4.01B $3.99B $3.98B $3.98B
Retained Earnings $1.96B $1.75B $1.72B $1.67B $1.67B
Less: Treasury Stock -$75.70M -$75.70M -$75.70M -$75.70M -$75.70M
Gains/Losses Not Affecting Retained Earnings -$76.50M -$55.20M -$43.70M -$16.90M -$16.90M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $195.10M $178.20M $58.70M $623.80M $152.70M
Net cash flow from continuing operations $195.10M $178.20M $58.70M $623.80M $152.70M
Net Income from Continuing Operations $203.40M $38.10M $43.30M -$530.20M $52.40M
Gain/Loss from Continuing Operations $1.20M $1.10M -$800,000.00 $29.50M $10.50M
Depreciation & Depletion & Amortization $105.30M $105.60M $105.00M $410.20M $103.30M
Deferred Tax -$147.20M $16.30M -$10.20M $7.70M $49.60M
Other Non-Cash Items $2.90M $8.40M $1.40M $10.40M $2.80M
Change in Working Capital -$2.00M -$22.10M -$100.40M -$198.90M -$97.50M
-Change in Receivables $12.40M -$39.90M -$40.80M $13.60M $3.10M
-Change in Inventory -$44.10M -$34.50M -$12.20M -$109.40M -$42.70M
-Change in Payables and Accrued Expense -$24.90M $26.90M -$10.30M $41.10M $58.90M
-Change In Other Working Capital $54.60M $25.40M -$37.10M -$144.20M -$116.80M
Net cash flow from investing -$38.50M -$37.30M -$32.70M -$130.50M -$39.70M
Net Cash Flow from Continuing Investing Activities -$38.50M -$37.30M -$32.70M -$130.50M -$39.70M
Capital Expenditure -$38.90M -$37.60M -$33.50M -$128.80M -$35.50M
Net Other Investing Changes $400,000.00 $300,000.00 $800,000.00 -$1.70M -$4.20M
Financing Cash Flow $1.80M -$112.40M -$107.20M -$409.40M $700,000.00
Net Cash Flow from Continuing Financing Activities $1.80M -$112.40M -$107.20M -$409.40M $700,000.00
Net Issuance Payments Of Debt -$9.10M -$112.10M -$105.40M -$318.70M $90.90M
Net Common Stock Issuance -$1.10M -$300,000.00 -$3.60M -$80.70M -$75.30M
Proceeds from Stock Option Exercised $12.70M $0.00 $1.90M $5.10M $200,000.00
Net Other Financing Charges -$700,000.00 $0.00 -$100,000.00 -$15.10M –
Ending Cash Balance $467.20M $309.70M $282.20M $368.30M $368.30M
Net Change in Cash $158.40M $28.50M -$81.20M $83.90M $113.70M
Beginning Cash Balance $309.70M $282.20M $368.30M $264.70M $254.70M
Effect of Exchange Rate Changes -$900,000.00 -$1.00M -$4.90M $19.70M -$100,000.00
Free Cash Flow $156.20M $140.60M $25.20M $495.00M $117.20M
Net Business Purchase and Sale – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on AVTR.

Sign in to join the discussion.

Scroll to Top